Kimia Therapeutics
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $55M
Overview
An AI-driven small molecule discovery company targeting difficult-to-drug proteins.
OncologyImmunology
Technology Platform
An integrated AI and automated chemistry platform designed to discover small molecules against challenging, high-value biological targets.
Funding History
1Total raised:$55M
Series A$55M
Opportunities
Potential to rapidly generate valuable preclinical assets for partnership or internal development across multiple high-need diseases.
Risk Factors
High risk of platform validation, as generating a clinical-stage asset is necessary to prove its advantage over traditional discovery.
Competitive Landscape
Competes with numerous AI-driven drug discovery startups (e.g., Recursion, Exscientia) by emphasizing a closed-loop chemistry and biology integration.